Invention Grant
- Patent Title: Reversible di-nucleotide terminator sequencing
- Patent Title (中): 可逆二核苷酸终止子测序
-
Application No.: US12275161Application Date: 2008-11-20
-
Publication No.: US08017338B2Publication Date: 2011-09-13
- Inventor: Gerald Zon
- Applicant: Gerald Zon
- Applicant Address: US CA Carlsbad
- Assignee: Life Technologies Corporation
- Current Assignee: Life Technologies Corporation
- Current Assignee Address: US CA Carlsbad
- Main IPC: C12Q1/68
- IPC: C12Q1/68

Abstract:
The present teachings provide methods, compositions, and kits for synthesizing and sequencing nucleic acids. In some embodiments, reversible di-nucleotide compounds are employed along with cleaving reactions that remove a label and a blocking moiety. Improved sequencing efficiency is achieved by the rapid polymerase-mediated incorporation of reversible di-nucleotide compounds. In some embodiments, the di-nucleotides do not contain conventional nucleotide triphosphates, but rather employ amino acid phosphoramidate nucleotides (AAPNs).
Public/Granted literature
- US20090263797A1 REVERSIBLE DI-NUCLEOTIDE TERMINATOR SEQUENCING Public/Granted day:2009-10-22
Information query